Number of patients with adverse events using WHO preferred terms
| WHO preferred term | 25 mg BIIL 284 | 150 mg BIIL 284 | Placebo | Total | ||||
|---|---|---|---|---|---|---|---|---|
| No | % | No | % | No | % | No | % | |
| Total treated | 7 | 100 | 9 | 100 | 10 | 100 | 26 | 100 |
| Total with any adverse event | 3 | 43 | 6 | 67 | 3 | 30 | 12 | 46 |
| Fatigue | 1 | 14 | 2 | 22 | 0 | 0 | 3 | 12 |
| Headache | 1 | 14 | 1 | 11 | 0 | 0 | 2 | 8 |
| Pallor | 1 | 14 | 0 | 0 | 0 | 0 | 1 | 4 |
| Weight increase | 0 | 0 | 1 | 11 | 0 | 0 | 1 | 4 |
| Hypertension | 1 | 14 | 0 | 0 | 0 | 0 | 1 | 4 |
| Hypotension | 0 | 0 | 1 | 11 | 0 | 0 | 1 | 4 |
| Vertigo | 0 | 0 | 1 | 11 | 1 | 10 | 2 | 8 |
| Constipation | 0 | 0 | 1 | 11 | 0 | 0 | 1 | 4 |
| Diarrhoea | 0 | 0 | 1 | 11 | 0 | 0 | 1 | 4 |
| Flatulence | 0 | 0 | 1 | 11 | 0 | 0 | 1 | 4 |
| Nausea | 0 | 0 | 1 | 11 | 0 | 0 | 1 | 4 |
| Aggravation of arthritis | 0 | 0 | 2 | 22 | 2 | 20 | 4 | 15 |
| Bronchitis | 1 | 14 | 0 | 0 | 0 | 0 | 1 | 4 |
| Dyspnoea | 1 | 14 | 1 | 11 | 0 | 0 | 2 | 8 |
| Upper resp. tract infection | 0 | 0 | 1 | 11 | 1 | 10 | 2 | 8 |
| Pruritus | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 4 |